ABbiotek Health
  • Our Locations
  • Contact Us
  • Search
ABFI
  • Dietary Supplements
    • Immune Health
    • Digestive Health
    • Mobility Health
  • Functional Food
    • Postbiotic Immune
    • Postbiotic Metabol
    • Postbiotic Digestive
  • Our Brands
    • ABB C1®
    • ABB C22®
    • adiDAO®
    • adiDAO® Microencapsulated
    • Arthelio®
    • Postbiotic Immune
    • Postbiotic Metabol
    • Postbiotic Digestive
  • About Us
    • Research
  • Blogs
  • News and Events
  • Contact Us
  • Our Locations
  • Contact Us
  1. Home
  2. News and Events
  3. News

News

News Events
Three Become One: Introducing our Unified Health & Nutrition Business

Three Become One: Introducing our Unified Health & Nutrition Business

28/10/2024
Eurecat present paper at IFHN-2024 congress exploring fibromyalgia drug interactions with DAO

Eurecat present paper at IFHN-2024 congress exploring fibromyalgia drug interactions with DAO

15/07/2024
Breakthrough research highlights transformative potential of beta-glucans for therapeutic applications.

Breakthrough research highlights transformative potential of beta-glucans for therapeutic applications.

17/04/2024
2023 Annual Results Announcement

2023 Annual Results Announcement

07/11/2023 Financial
Tetra Pak and AB Biotek HNH introduce new opportunities for postbiotic food and drinks

Tetra Pak and AB Biotek HNH introduce new opportunities for postbiotic food and drinks

01/11/2023
ABB C1®: Training Now for Future Immune Challenges

ABB C1®: Training Now for Future Immune Challenges

18/10/2023
09/2023 Pre Close Period Trading Update

09/2023 Pre Close Period Trading Update

12/09/2023 Financial
Q3 2023 Trading Update

Q3 2023 Trading Update

26/06/2023 Financial
2023 Interim Results Announcement

2023 Interim Results Announcement

25/04/2023 Financial
02/2023 Pre Close Period Trading Update

02/2023 Pre Close Period Trading Update

27/02/2023 Financial
Why postbiotics are expected to become increasingly important in the world of biotics

Why postbiotics are expected to become increasingly important in the world of biotics

21/02/2023
Research paper describing ABB C1™ studies published in Nutraceuticals journal

Research paper describing ABB C1™ studies published in Nutraceuticals journal

07/02/2023
  • Older
  • Terms and Conditions
  • Privacy Notice
  • Cookies
  • Modern Slavery

Copyright © 2025 ABbiotek Health

ABF Ingredients (ABFI) logo AB Biotek logo AB Enzymes logo Abitec Fyxetia Ohly logo PGP International logo SPI Pharma logo

This website is intended to provide information about ABbiotek Health’s ingredients, used in various food/dietary supplement products around the world. It is only intended for business-to-business communication and to provide information to food/dietary supplement professionals and is not designed for the general public.

As ABbiotek Health’s ingredients are being marketed in a large number of countries, it is the responsibility of each of our customers to ensure that the use of the ingredient and any claim made in the labelling or advertising of the ingredient or finished product comply with the applicable rules and regulations of the country or countries in which the product is to be sold.

Please confirm that you are a food/dietary supplement professional before entering the site.